REDUCING RISK OF TYPE 2 DIABETES (T2D)

摘要

This invention relates to methods for reducing chronic subacute inflammat ory states associated with obesity and improve glycemia, thereby preventing or delaying the development of type 2 diabetes (T2D) in obese subjects, or s ubjects with the metabolic syndrome, using non-acetylated forms of salicylat e, e.g., salsalate or trilisate.